Century Therapeutics, Inc.

3675 Market Street, Suite 200
United States

Show jobs for this employer

About Century Therapeutics, Inc.

Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care.

3 articles with Century Therapeutics, Inc.